Cargando…
POS-045 EARLY RENAL REPLACEMENT THERAPY MAY REDUCE THE ALL-CAUSE MORTALITY OF SEVERE COVID-19
Autores principales: | Qian, J., Wang, M., You, H., Luo, J., Li, S., Chen, S., Chen, Y., Li, X., Wang, K., Zhang, W.Z., Yuan, L., Ni, L., Chen, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049697/ http://dx.doi.org/10.1016/j.ekir.2021.03.051 |
Ejemplares similares
-
POS-290 MORTALITY IN COVID-19 PATIENTS WITH CKD WITH AND WITHOUT KIDNEY REPLACEMENT THERAPY IN WESTERN MEXICO
por: GARCIA RIVERA, A., et al.
Publicado: (2022) -
POS-540 COVID-19 IN ESRD PATIENTS WITH RENAL REPLACEMENT THERAPIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Nopsopon, T., et al.
Publicado: (2021) -
POS-918 ADVERSE EVENTS OF COVID-19 VACCINES IN RENAL TRANSPLANT RECIPIENTS
por: WONG, J.M., et al.
Publicado: (2022) -
POS-950 COVID-19 IN END STAGE KIDNEY DISEASE WITH RENAL REPLACEMENT THERAPIES: OUR EXPERIENCE IN PENANG
por: LEE, S.Y., et al.
Publicado: (2022) -
POS-962 A SURVEY OF COVID-19 INFECTION AMONG VACCINATED AND UNVACCINATED PATIENTS ON RENAL REPLACEMENT THERAPY: A SINGLE CENTRE EXPERIENCE
por: Lim, H.Y., et al.
Publicado: (2022)